Advertisement
Advertisement

PRCT

PRCT logo

PROCEPT BioRobotics Corporation Common Stock

22.76
USD
Sponsored
+1.39
+6.50%
Sep 04, 15:59 UTC -4
Closed
exchange

After-Market

22.55

-0.21
-0.90%

PRCT Earnings Reports

Positive Surprise Ratio

PRCT beat 11 of 20 last estimates.

55%

Next Report

Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$103.12M
/
-$0.39
Implied change from Q2 26 (Revenue/ EPS)
+9.13%
/
-17.02%
Implied change from Q3 25 (Revenue/ EPS)
+23.76%
/
+2.63%

PROCEPT BioRobotics Corporation Common Stock earnings per share and revenue

On Aug 04, 2026, PRCT reported earnings of -0.47 USD per share (EPS) for Q2 26, missing the estimate of -0.46 USD, resulting in a -0.84% surprise. Revenue reached 94.50 million, compared to an expected 94.75 million, with a -0.27% difference. The market reacted with a +5.80% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 14 analysts forecast an EPS of -0.39 USD, with revenue projected to reach 103.12 million USD, implying an decrease of -17.02% EPS, and increase of 9.13% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Electromed, Inc.
Report Date
Aug 25, 2026 For Q4 26
Estimate
$0.31
Actual
$0.39
Surprise
+23.34%
FAQ
For Q2 2026, PROCEPT BioRobotics Corporation Common Stock reported EPS of -$0.47, missing estimates by -0.84%, and revenue of $94.50M, -0.27% below expectations.
The stock price moved up 5.8%, changed from $18.28 before the earnings release to $19.34 the day after.
The next earning report is scheduled for Nov 02, 2026.
Based on 14 analysts, PROCEPT BioRobotics Corporation Common Stock is expected to report EPS of -$0.39 and revenue of $103.12M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement